Date Filed | Type | Description |
10/10/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
10/03/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ... |
08/22/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
08/15/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
08/10/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
08/03/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ... |
08/01/2023 |
8-K
| Quarterly results |
07/31/2023 |
8-K
| Quarterly results |
07/25/2023 |
8-K
| Quarterly results |
07/21/2023 |
8-K
| Quarterly results |
07/17/2023 |
8-K
| Quarterly results |
07/11/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
07/06/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
07/06/2023 |
8-K
| Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits Interactive Data |
07/06/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
06/29/2023 |
SC 13D
| Cincinnati Cornerstone Investors BWV I, LLC reports a 0% stake in Blue Water Biotech, Inc. |
06/06/2023 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
05/15/2023 |
8-K
| Investor presentation |
05/12/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
05/10/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
05/05/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
04/28/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
04/26/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
04/24/2023 |
8-K
| Quarterly results |
04/20/2023 |
8-K
| Quarterly results |
03/29/2023 |
8-K
| Quarterly results |
03/29/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
03/17/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
03/13/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
03/09/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
02/14/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
01/31/2023 |
SC 13G
| AMERICAN FINANCIAL GROUP INC reports a 6.1% stake in BLUE WATER VACCINES INC. |
01/17/2023 |
8-K
| Resignation/termination of a director |
01/09/2023 |
8-K
| Quarterly results |
|